Article: P23 Amitryptilin strengthens effects of bortezomib and melphalan treatment in multiple myeloma by inhibiting acid sphingomyelinase

€3.03

SKU: product-article-15302 Category: General

Description
Reviews (0)

Description

P23 Amitryptilin strengthens effects of bortezomib and melphalan treatment in multiple myeloma by inhibiting acid sphingomyelinase

Reviews

There are no reviews yet.

Be the first to review “Article: P23 Amitryptilin strengthens effects of bortezomib and melphalan treatment in multiple myeloma by inhibiting acid sphingomyelinase”

You must be logged in to post a review.

Top

Article: P23 Amitryptilin strengthens effects of bortezomib and melphalan treatment in multiple myeloma by inhibiting acid sphingomyelinase

Description

Reviews

Related products

1 year access Online Belgian Journal of Hematology (BJH)

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Highlights in melanoma

Article: Highlights in digestive oncology